Evidence map›Paper›PMID 33982369›Full record

ArticleProtein science : a publication of the Protein Society2021

Electrostatic modulation of hnRNPA1 low-complexity domain liquid-liquid phase separation and aggregation.

Phoebe S Tsoi, My Diem Quan, Kyoung-Jae Choi, Khoa M Dao, Josephine C Ferreon, Allan Chris M Ferreon

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Biomolecular condensates and disease pathogenesis.Science China. Life sciences · 2024
    Review
  14. Article
  15. Liquid-liquid phase separation in hepatocellular carcinoma.Frontiers in cell and developmental biology · 2024
    Review
  16. RNA binding proteins in cardiovascular development and disease.Current topics in developmental biology · 2024
    Article
  17. Article
  18. Multiscale Modeling of Protein-RNA Condensation in and Out of Equilibrium.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  19. Fluorescence Lifetime Imaging Microscopy of Biomolecular Condensates.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Phoebe S TsoiDepartment of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, Texas, USA.
My Diem QuanDepartment of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, Texas, USA.
Kyoung-Jae ChoiDepartment of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, Texas, USA.
Khoa M DaoDepartment of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, Texas, USA.
Josephine C FerreonDepartment of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, Texas, USA.
Allan Chris M FerreonDepartment of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0002-8538-1732
Baylor College of Medicine · US

Funding

Structure and Functionof Nanog in Stem Cell PluripotencyR01GM122763 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI Josephine Chu Ferreon · 2018 to 2026
$3.4M
Phase Transition-Mediated Tau Function and DysfunctionR01NS105874 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI FERREON, ALLAN CHRIS · 2019 to 2023
$2.0M
Pharmacologic inhibition of ribonucleoprotein droplet maturationR21NS109678 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI FERREON, ALLAN CHRIS · 2019 to 2019
$440k
Mechanism of Pathologic hnRNP Droplet MaturationR21NS107792 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI FERREON, ALLAN CHRIS · 2019 to 2019
$439k
Folding, Misfolding and Oligomerization of TDP-43F31NS103380 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI TSOI, PHOEBE SISOEN · 2018 to 2020
$135k
NIGMS NIH HHS R01 GM122763NINDS NIH HHS F31 NS103380NINDS NIH HHS R01 NS105874NINDS NIH HHS R21 NS107792NINDS NIH HHS R21 NS109678
6 · The paper itself

Abstract

Membrane-less organelles and RNP granules are enriched in RNA and RNA-binding proteins containing disordered regions. Heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1), a key regulating protein in RNA metabolism, localizes to cytoplasmic RNP granules including stress granules. Dysfunctional nuclear-cytoplasmic transport and dynamic phase separation of hnRNPA1 leads to abnormal amyloid aggregation and neurodegeneration. The intrinsically disordered C-terminal domain (CTD) of hnRNPA1 mediates both dynamic liquid-liquid phase separation (LLPS) and aggregation. While cellular phase separation drives the formation of membrane-less organelles, aggregation within phase-separated compartments has been linked to neurodegenerative diseases. To understand some of the underlying mechanisms behind protein phase separation and LLPS-mediated aggregation, we studied LLPS of hnRNPA1 CTD in conditions that probe protein electrostatics, modulated specifically by varying pH conditions, and protein, salt and RNA concentrations. In the conditions investigated, we observed LLPS to be favored in acidic conditions, and by high protein, salt and RNA concentrations. We also observed that conditions that favor LLPS also enhance protein aggregation and fibrillation, which suggests an aggregation pathway that is LLPS-mediated. The results reported here also suggest that LLPS can play a direct role in facilitating protein aggregation, and that changes in cellular environment that affect protein electrostatics can contribute to the pathological aggregation exhibited in neurodegeneration.

Indexed as

Protein AggregatesHeterogeneous Nuclear Ribonucleoprotein A1HumansIntrinsically Disordered ProteinsProtein DomainsStatic ElectricityHeterogeneous Nuclear Ribonucleoprotein A1hnRNPA1 protein, humanIntrinsically Disordered ProteinsProtein AggregatesALShnRNPA1intrinsically disordered proteinLLPSneurodegenerative diseasesprotein aggregation

Identifiers

PMID33982369
PMCPMC8197420
OpenAlexW3161332246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.